A Study to EValuate the Efficacy and Safety of JTE-051 on Subjects with Active Rheumatoid Arthritis (MOVE-RA) A Study to EValuate the Efficacy and Safety of JTE-051on Subjects with Active Rheumatoid Arthritis ( ...
A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects with Active Rheumatoid Arthritis (MOVE-RA) - MOVE-RA A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Ef ...
Product Name: JTE-051 Product Code: JTE-051 INN or Proposed INN: No proposed INN available Other descriptive name: JTE-051Product Name: JTE-051 Product Code: JTE-051 INN or Proposed INN: No proposed INN available Other descri ...
Akros Pharma Inc.
NULL
Not Recruiting
Female: yes Male: yes
250
Phase 2
United States;Mexico;Argentina;Poland;Ukraine;Romania;Peru;Russian Federation;Bulgaria;Colombia
A Study to EValuate the Efficacy and Safety of JTE-051 in Subjects with Active Rheumatoid Arthritis (MOVE-RA) A Study to EValuate the Efficacy and Safety of JTE-051in Subjects with Active Rheumatoid Arthritis ( ...
A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects with Active Rheumatoid Arthritis (MOVE-RA) - MOVE-RA A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Ef ...
Product Name: JTE-051 Product Code: JTE-051 INN or Proposed INN: No proposed INN available Other descriptive name: JTE-051Product Name: JTE-051 Product Code: JTE-051 INN or Proposed INN: No proposed INN available Other descri ...
Akros Pharma Inc.
NULL
Not Recruiting
Female: yes Male: yes
250
Phase 2
United States;Mexico;Argentina;Poland;Ukraine;Romania;Peru;Russian Federation;Bulgaria;Colombia
Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis Study to Evaluate Efficacy, Safety and Tolerability of JTE-051in Subjects With Active Rheumatoid Art ...
A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Efficacy and Safety of JTE-051 Administered for 12 Weeks to Subjects With Active Rheumatoid Arthritis (MOVE-RA) A Multicenter, Randomized, Double-blind, PlacebO-controlled, Parallel-group Study to EValuate the Ef ...
Rheumatoid Arthritis
Drug: JTE-051;Drug: Placebo
Akros Pharma Inc.
NULL
Completed
18 Years
75 Years
All
260
Phase 2
United States;Argentina;Bulgaria;Colombia;Mexico;Peru;Poland;Romania;Russian Federation;Ukraine